The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Imprivata sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights N

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Imprivata is an authentication and access management technology solution. The company offers Imprivata onesign, an integrated enterprise single sign-on, authentication management and workflow automation platform that addresses multiple security and productivity. The company also provides Imprivata Cortext, a cloud-supported secure communications platform that provides healthcare organizations with secure SMS (short message services). It also offers Imprivata confirm ID, a comprehensive identity and two-factor authentication platform for the healthcare enterprise. Imprivata also provides Imprivata patientsecure, an identification solution that uses palm vein recognition biometrics to identify the patients. The company operates in the US, the UK, France, Germany, and the Netherlands. Impravata is headquartered in Lexington, Massachusetts, the US. Key subsidiaries of Imprivata include OGiTiX Software, SecureLink, Xton Technologies, Fairwarning and GroundControl Solutions.

The key metrics of Imprivata related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Imprivata is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Imprivata.

For a detailed understanding of the performance of Imprivata, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.